Navigation Links
Mayo Clinic study finds two genes predict outcome for breast cancer patients

Mayo Clinic researchers report that the expression of two novel genes within the tumors of women with early stage breast cancer may allow identification of women who are and are not at risk for early relapse or cancer-related death. Results of the study are published in the April 1 issue of Clinical Cancer Research.

"The HOXB13 and IL17BR gene profile was previously discovered as a potential marker of relapse in hormone-receptor positive breast cancer treated with tamoxifen," says Matthew Goetz, M.D., who co-led the project with James Ingle, M.D. and Fergus Couch, Ph.D. "Our new study shows that the marker is only useful for identifying women with a higher risk in the setting of lymph node-negative breast cancer."

The study, which was conducted by researchers at Mayo Clinic, Harvard Medical School and Arcturus Bioscience, tested whether the expression levels of two genes within women with early stage breast cancer affected the outcomes of women with estrogen receptor-positive breast cancer. The research team examined tissue from 206 postmenopausal women enrolled in a prospective study conducted by the North Central Cancer Treatment Group (NCCTG). They tested the level of gene expression of HOXB13 and IL17BR from paraffin-embedded tumors and found that the 2-gene expression ratio was an independent marker of early breast cancer relapse or death in lymph node-negative breast cancer.

"We believe that these findings are clinically important and corroborate the accumulating laboratory data which suggests that the HOXB13 gene is critically involved in breast cancer metastases," says Dr. Goetz. "Further research is needed to determine whether more aggressive or additional treatments will improve the outcomes of women identified to be at high risk by means of this marker."

Breast cancer is diagnosed in approximately one million women each year, and claims the lives of over 40,000 in the United States. More than two-thirds of all breast
'"/>

Source:Mayo Clinic


Page: 1 2

Related biology news :

1. Mayo Clinic Researchers Create Obedient Virus; First Step To Use Measles Virus Against Cancer
2. Chronic Sinus Infection Thought To Be Tissue Issue, Mayo Clinic Scientists Show Its Snot
3. Clinical trial to test stem cell approach for children with brain injury
4. Mayo Clinic collaboration discovers protein amplifies DNA injury signals
5. Mayo Clinic researchers challenge sepsis theory
6. Mayo Clinic researchers discover cancer cells may move via wave stimulation
7. Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
8. Mayo Clinic collaboration mining of ancient herbal text leads to potential new anti-bacterial drug
9. Mayo Clinic study suggests that a central nervous system viral infection can lead to memory deficits
10. Mayo Clinic: Gene expression profiling not quite perfected in predicting lung cancer prognosis
11. Bioartificial kidney under study at MCG

Post Your Comments:
(Date:11/30/2009)...d to monitor the commitments that will be made by ...forestation rates, according to research at the Un...s and research groups have failed to make full use...,s surface collected each week to monitor tropical...Grainger in the Proceedings of the National Acade...
(Date:11/30/2009)...state of Antarctica,s climate and its relationship...ek (Tuesday 1 December) by the Scientific Committe...rctic Climate Change and the Environment presents...ifies areas for future scientific research, and ad...ve about Antarctic melting, sea-level rise and bio...
(Date:11/30/2009)...ert at the holiday table are even less of a help t...g to a new research report recently appearing onli...), a diet that is high in fat and in sugar actuall...es to store too much fat. This means these foods h...lt task of converting high-fat and high-sugar food...
Breaking Biology News(10 mins):World forest observatory needed to monitor vital role of forests in climate deal 2First comprehensive review of the state of Antarctica's climate 2Happy holidays from the groaning board; Western diets turn on fat genes 2Radiation Plus Chemo a Good Option in Lung Cancer 52797 1Radiation Plus Chemo a Good Option in Lung Cancer 52797 2Grant for brain tumor and deafness research 52795 1Grant for brain tumor and deafness research 52795 2Genetic testing may be valuable in treating colorectal cancer 52793 1Genetic testing may be valuable in treating colorectal cancer 52793 2
...HO, N.Y., June 5 bioMETRX Inc., (OTC,Bulletin Boa...sumer-based,finger-activated products, today annou...ric Solutions, LLC, to co-develop a new generation... technology to consumers at,an accelerated rate, g..."Biometric Solutions, LLC has had successful engin...
...research team has uncovered the likely target of n...ide a clearer picture of how this vitamin helps ma...d and thus lower the risk of heart disease. , Whi...anism of how it works has been mysterious, althoug...ease HDL production. Recent work had uncovered tha...
...This release is available in German . , Leipzig....mental Research have developed two new methods, in...f European Otters (Lutra lutra) and their effects ...eeded for the first time in gathering more accurat...nd region of the Oberlausitz Biosphere Reserve. Ge...
Other Biology News:bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology 2bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology 3Otters reveal their identity 2Otters reveal their identity 3Otters reveal their identity 4
(Date:11/30/2009)...30 BioMarin Pharmaceutic...Food and Drug Administration (FDA) has granted orp...DAP), amifampridine phosphate, for the rare autoim...MS). 3,4-DAP has previously received orphan drug ...e Committee for Medicinal Products for Human Use o...
(Date:11/30/2009)...GEN, Nov. 30 Exiqon A/S (NASDAQ OM...ard Medical School ICCB-Longwood Screening Facilit...ning Center of Excellence. ICCB-L supports invest...hospitals and institutions, for high-throughput sc..., MicroRNAs are a novel class of small, non-coding...
(Date:11/30/2009)..., AMSTERDAM, November 30 /PRNewswire-FirstC... scientific, medical and technical products and se...e, its comprehensive biomedical,database which hol...7,000,active, peer reviewed journals. , E...t of new biomedical,and pharmaceutical insights. N...
(Date:11/27/2009)...Nov. 27 Cromoz Inc., located in Re...carbon nanotube-based cancer drug delivery system ...tubes, which have functional groups on the walls t...developed in partnership with the Indian Institute...serves as a drug delivery vehicle with the ability...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...e next installment covering the enforcement tactic...week. , , You or your company may have no paten...cerned with patent matters. However, there is a gr...tents to be a main or significant source of revenu... to be concerned with patent matters. , ,In the pa...
...ital Forum has issued an open call for companies ...re venture capitalists, corporate and private inve...thering April 5-6. , ,Dec. 16 is the early applica...n deadline to be considered for participation in t...nal headquarters in St. Louis. , ,Selection of pre...
...z about how gaming is going to transform corporate...em Advanced Distributed Learning Co-Lab are doin...knowledge, learning and industry. , ,Guess what? ... reroute the focus of innovation and development f... great time of year to get a feel for the scope an...
Other Biology Technology:Patent enforcement: What you don't know might hurt you 2Patent enforcement: What you don't know might hurt you 3Patent enforcement: What you don't know might hurt you 4Just in time for Christmas: Retail IT. 2Just in time for Christmas: Retail IT. 3
... DuoSet ELISA Development kit contains the basic c... ELISAs to measure natural and recombinant mouse D...es and serum. Each kit contains sufficient materia...plates, provided that the following conditions are...
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
RayBio Mouse AngiogenesisAntibody Array I & 1.1 Service from Raybiotech, Inc.
Biology Products: